JP2016512537A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512537A5
JP2016512537A5 JP2016501522A JP2016501522A JP2016512537A5 JP 2016512537 A5 JP2016512537 A5 JP 2016512537A5 JP 2016501522 A JP2016501522 A JP 2016501522A JP 2016501522 A JP2016501522 A JP 2016501522A JP 2016512537 A5 JP2016512537 A5 JP 2016512537A5
Authority
JP
Japan
Prior art keywords
stable
prescription
ara
allergen
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016501522A
Other languages
English (en)
Japanese (ja)
Other versions
JP6752140B2 (ja
JP2016512537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/024401 external-priority patent/WO2014159607A1/en
Publication of JP2016512537A publication Critical patent/JP2016512537A/ja
Publication of JP2016512537A5 publication Critical patent/JP2016512537A5/ja
Priority to JP2019034083A priority Critical patent/JP6891205B2/ja
Application granted granted Critical
Publication of JP6752140B2 publication Critical patent/JP6752140B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016501522A 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造 Active JP6752140B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019034083A JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784964P 2013-03-14 2013-03-14
US61/784,964 2013-03-14
PCT/US2014/024401 WO2014159607A1 (en) 2013-03-14 2014-03-12 Manufacture of peanut formulations for oral desensitization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034083A Division JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造

Publications (3)

Publication Number Publication Date
JP2016512537A JP2016512537A (ja) 2016-04-28
JP2016512537A5 true JP2016512537A5 (enExample) 2017-04-20
JP6752140B2 JP6752140B2 (ja) 2020-09-09

Family

ID=51528061

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016501522A Active JP6752140B2 (ja) 2013-03-14 2014-03-12 経口脱感作のための落花生処方物の製造
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019034083A Active JP6891205B2 (ja) 2013-03-14 2019-02-27 経口脱感作のための落花生処方物の製造
JP2021025462A Active JP7454519B2 (ja) 2013-03-14 2021-02-19 経口脱感作のための落花生処方物の製造

Country Status (19)

Country Link
US (5) US9198869B2 (enExample)
EP (3) EP3998080A1 (enExample)
JP (3) JP6752140B2 (enExample)
CN (2) CN105101994B (enExample)
AU (5) AU2014240404B2 (enExample)
BR (1) BR112015021756B1 (enExample)
CA (1) CA2903229A1 (enExample)
DK (2) DK3482771T3 (enExample)
ES (2) ES2826224T3 (enExample)
FI (2) FI3482771T3 (enExample)
FR (1) FR23C1026I2 (enExample)
HU (1) HUE051831T2 (enExample)
MX (1) MX2015010315A (enExample)
NL (1) NL301236I2 (enExample)
NO (1) NO2023027I1 (enExample)
PL (1) PL2968529T3 (enExample)
PT (1) PT2968529T (enExample)
SI (1) SI2968529T1 (enExample)
WO (1) WO2014159607A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2924349B1 (fr) 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
SI2968529T1 (sl) 2013-03-14 2021-03-31 Aimmune Therapeutics, Inc. Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo
KR102541110B1 (ko) 2014-08-25 2023-06-08 에이뮨 테라퓨틱스, 인코퍼레이티드 난 단백질 제형 및 이의 제조 방법
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
FI3258962T3 (fi) 2015-02-20 2023-04-12 Sekoitetut allergeenikoostumukset ja menetelmät niiden käyttämiseksi
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
TW201709926A (zh) * 2015-04-23 2017-03-16 賽諾菲公司 用於舌下投藥之吡喃葡萄糖基脂a及過敏原調配物
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
PT3548079T (pt) * 2016-12-05 2023-07-27 Reacta Biotech Ltd Formulações de refeições para provocação oral
MX2019008419A (es) * 2017-01-13 2019-12-02 Aimmune Therapeutics Inc Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim
US11382934B2 (en) 2017-07-18 2022-07-12 Before Brands, Inc. Methods for making mixed allergen compositions
CA3080601A1 (en) 2017-11-02 2019-05-09 Aimmune Therapeutics, Inc. Methods of oral immunotherapy
GB201718342D0 (en) * 2017-11-06 2017-12-20 Cambridge Allergy Ltd Allergenic protein formulations for immunotherapy
SG11202006732WA (en) 2018-01-16 2020-08-28 Tel Hashomer Medical Res Infrastructure & Services Ltd Treatment and prevention of seed allergies
CN112638413A (zh) 2018-07-27 2021-04-09 艾慕恩治疗公司 口服免疫治疗单位剂量分配系统和方法
EP3836801A4 (en) 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
AU2019401576A1 (en) * 2018-12-17 2021-06-24 Société des Produits Nestlé S.A. Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CN113891722A (zh) * 2018-12-20 2022-01-04 爱沐疗法公司 用于漏服剂量的花生口服免疫疗法给药计划表
CA3127337A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions
EP3965815A4 (en) 2019-05-10 2023-05-31 Société des Produits Nestlé S.A. METHOD OF IMPROVING THE QUALITY OF LIFE IN A PEANUT ALLERGY PATIENT
MX2022001568A (es) * 2019-08-08 2022-03-02 Evonik Operations Gmbh Procedimiento de preparacion de una forma de dosificacion solida y un lubricante.
WO2021102186A1 (en) * 2019-11-20 2021-05-27 Aimmune Therapeutics, Inc. Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
EP4081251A4 (en) * 2019-12-23 2024-03-20 Prota Therapeutics Pty Ltd PHARMACEUTICAL COMPOSITIONS
US12357226B2 (en) 2020-07-01 2025-07-15 Société des Produits Nestlé S.A. Determining medical staffing for oral immunotherapy
AU2022206434A1 (en) 2021-01-08 2023-08-24 Regeneron Pharmaceuticals, Inc. Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
CA3255134A1 (en) 2022-04-11 2023-10-19 Alk Abello As PEANUT ALLERGEN COMPOSITION

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3809767A (en) * 1969-05-12 1974-05-07 Griffith Laboratories Methods of making vegetable protein concentrates
WO1992015285A1 (en) 1991-03-01 1992-09-17 Warner-Lambert Company Starch-based controlled release compositions
US20120164306A1 (en) * 1993-08-03 2012-06-28 Girsh Leonard S Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) * 1994-09-10 2003-09-08 株式会社林原生物化学研究所 ペプチドとその用途
WO2001040264A2 (en) 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Peptide antigens
ES2260078T3 (es) 2000-04-06 2006-11-01 Seer Pharmaceuticals, Llc. Sistema de administracion microbiana.
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
EP2545931A1 (en) 2004-03-19 2013-01-16 Herbs Spring, LLC Herbal therapy for the treatment of food allergy
JP2009522258A (ja) * 2005-12-28 2009-06-11 テバ ファーマシューティカル インダストリーズ リミティド 増大したバイオアベイラビリティを有するフェノフィブラートの医薬製剤
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
WO2010059534A2 (en) 2008-11-19 2010-05-27 Mallinckrodt Baker, Inc. Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
CA2737335C (en) 2008-12-19 2013-10-01 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) 2010-02-12 2011-09-14 Centro De Ingenieria Genetica Y Biotecnologia Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es) * 2010-06-30 2012-10-17 Novartis Ag Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) * 2010-08-09 2015-07-15 刘会梅 银杏内酯b脂质体组合药物
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
JP2014525458A (ja) * 2011-08-31 2014-09-29 ペロスフィア インコーポレイテッド アレルギー患者を有効かつ迅速に脱感作するための方法
WO2013087119A1 (en) * 2011-12-16 2013-06-20 Hal Allergy Holding B.V. Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
US9492535B2 (en) * 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
SI2968529T1 (sl) 2013-03-14 2021-03-31 Aimmune Therapeutics, Inc. Izdelava arašidovih formulacij arašida za ustno desenzibilizacijo
KR102541110B1 (ko) 2014-08-25 2023-06-08 에이뮨 테라퓨틱스, 인코퍼레이티드 난 단백질 제형 및 이의 제조 방법
MX2019008419A (es) 2017-01-13 2019-12-02 Aimmune Therapeutics Inc Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral.
CA3080601A1 (en) 2017-11-02 2019-05-09 Aimmune Therapeutics, Inc. Methods of oral immunotherapy

Similar Documents

Publication Publication Date Title
JP2016512537A5 (enExample)
JP2015520667A5 (enExample)
JP2017500760A5 (enExample)
TR201909746T4 (tr) Pestisit işlevine sahip moleküller ve bunlarla ilişkili ara maddeler, bileşim ve işlemler.
JP2015081257A5 (enExample)
EA201991293A1 (ru) Получение новых препаратов на основе бета-лактоглобулина и связанные с ними способы, варианты применения и продукты питания
JP2016508542A5 (enExample)
BR112017017089A2 (pt) complexos de acetato de abiraterona, processo para preparação destes e composições farmacêuticas contendo-os
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
JP2016511287A5 (enExample)
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
MX2018007594A (es) Proceso de produccion y de purificacion del 2,3,3,3-tetrafluoropro peno.
DK3601252T3 (da) Tetrahydrat af H3-ligand, fremgangsmåde til fremstilling deraf og farma-ceutiske sammensætninger omfattende samme
EP3651587A4 (en) COMPOSITIONS RICH IN PROTEIN AND THEIR PREPARATION AND USE PROCESS
CN109563035A (zh) 9-氨基甲基取代的四环素类化合物的晶型及其制备方法
RU2015126587A (ru) Способ повышения урожайности озимой пшеницы
WO2016073493A3 (en) Antifibrinolytic compounds
CN106414485A8 (zh) 人工活化的毒性肽
GB201704384D0 (en) N-((3,4,5-Trimethoxystyryl)aryl) cinnamamide compounds as potential anticancer agents and process for the preparation thereof
CN302508771S (zh) 床屏饰件(蝶形)
TH177123A (th) โซฟอสบิวเวียร์ในรูปผลึกและกระบวนการสำหรับการเตรียมของสารนั้น
TH156083A (th) กรรมวิธีการดัดแปลงแป้งกล้วยโดยการดัดแปรทางเคมีเพื่อใช้ในอุตสาหกรรมเครื่องสำอาง
UA62421U (ru) Способ получения эстеров и нитрилов n-ацилиминотрихлоропропановых кислот
CN302094599S (zh) 揉面机(kf-105)
CN302386435S (zh) 饼(相思饼)